Mesa Laboratories Inc (MLAB) |
|
Price: $101.0800
$1.23
1.232%
|
Day's High:
| $103.25
| Week Perf:
| -5.38 %
|
Day's Low: |
$ 98.33 |
30 Day Perf: |
4.06 % |
Volume (M): |
53 |
52 Wk High: |
$ 187.75 |
Volume (M$): |
$ 5,307 |
52 Wk Avg: |
$122.29 |
Open: |
$99.21 |
52 Wk Low: |
$82.86 |
|
|
Market Capitalization (Millions $) |
545 |
Shares
Outstanding (Millions) |
5 |
Employees |
276 |
Revenues (TTM) (Millions $) |
213 |
Net Income (TTM) (Millions $) |
1 |
Cash Flow (TTM) (Millions $) |
2 |
Capital Exp. (TTM) (Millions $) |
3 |
Mesa Laboratories Inc
Mesa Laboratories, Inc. was incorporated under the laws of the State of Colorado
on March 26, 1982. We pursue a strategy of focusing primarily on quality control
products, which are sold into niche markets that are driven by regulatory requirements.
We prefer markets that have limited competition where we can establish a commanding
presence and achieve high gross margins. We are organized into three divisions
across six physical locations. Our Instruments Division designs, manufactures
and markets quality control instruments and disposable products utilized in
connection with the healthcare, pharmaceutical, food and beverage, medical device,
industrial hygiene, environmental air sampling and semiconductor industries.
Our Biological Indicators Division manufactures and markets biological indicators
and distributes chemical indicators used to assess the effectiveness of sterilization
processes, including steam, hydrogen peroxide, ethylene oxide and radiation,
in the hospital, dental, medical device and pharmaceutical industries. Our Continuous
Monitoring Division designs, develops and markets systems which are used to
monitor various environmental parameters such as temperature, humidity and differential
pressure to ensure that critical storage and processing conditions are maintained
in hospitals, pharmaceutical and medical device manufacturers, blood banks,
pharmacies and a number of other laboratory and industrial environments.
Our Lakewood, Colorado, and Butler, New Jersey, facilities manufacture our
Instruments Division products which include the DataTrace®, DialyGuard®,
DryCal®, Torqo®, SureTorque® and BGI brands. Our Omaha, Nebraska,
and Bozeman, Montana locations manufacture our Biological Indicators Division
products which include the Mesa, PCD® and Apex® brands, while our Lakewood,
Colorado, facility also manufactures our Continuous Monitoring Division products
which include CheckPoint® and AmegaView brands.
Our philosophy is to manufacture exceptional quality products and provide a
high level of on-going service for those products. Our revenues come from two
main sources – product sales and services. Our strategic goals involve
continuing to grow revenues and profits through three key strategies –
a) improving our distribution channels, b) introducing new products to the market,
and c) seeking out companies or product lines to acquire.
Product sales are dependent on several factors, including general economic
conditions, both domestic and international, customer capital spending trends,
competition, introduction of new products and acquisitions. Biological indicator
products are disposable and are used on a routine basis for quality control,
thus product sales are less sensitive to general economic conditions. Instrument
products and continuous monitoring systems have a longer life, and their purchase
by our customers is somewhat discretionary, so sales are more sensitive to general
economic conditions. Service demand is driven by our customers’ quality
control and regulatory environments, which require periodic repair and recalibration
or certification of our instrument products and continuous monitoring systems.
We typically evaluate costs and pricing annually. Our policy is to price our
products competitively and, where possible, we try to pass along cost increases
in order to maintain our margins.
Company Address: 12100 West Sixth Avenue Lakewood 80228 CO
Company Phone Number: 987-8000 Stock Exchange / Ticker: NASDAQ MLAB
|
|
|
|
|
Stock Performances by Major Competitors |
|
|
Announcement
Published Fri, Mar 15 2024 11:00 AM UTC
In a bid to reinforce its dedication to ethical and sustainable business practices, Mesa Laboratories, Inc. has unveiled its second annual Environmental, Social, and Governance (ESG) Program Brochure. With a focus on protecting vulnerable communities and fostering environmental stewardship, social responsibility, and strong corporate governance, Mesa Labs is positioning itse...
|
Mesa Laboratories Inc
Mesa Laboratories Inc, a global leader in life science tools and quality control solutions, recently announced its financial results for the third fiscal quarter ended December 31, 2023. Despite a decrease in revenue, the company managed to significantly increase its earnings per share, with net profit per share soaring by 387.5% to $0.39 per share. This positive financial performance is a testament to the company's ability to adapt and thrive in challenging market conditions. However, it's worth noting that Mesa Laboratories Inc stock has experienced a downward trend in the past 5 trading days, with a decrease of -2.52%. This brings the year-to-date performance to -11.54%. Furthermore, the stock is trading only 13.4% above its 52-week low, indicating potential challenges ahead for the company.
|
Dividend
Published Tue, Oct 3 2023 12:01 PM UTC
LAKEWOOD, Colo., Oct. 03, 2023 - Mesa Laboratories, Inc. (NASDAQ:MLAB) announced today that its Board of Directors has approved a regular quarterly dividend of $0.16 per share of common stock. This noteworthy declaration is set to impact shareholders, offering them both reassurance and potential rewards. The dividend will be payable on December 15, 2023, to sha...
|
Mesa Laboratories Inc
/>This article evaluates the recent financial performance of Mesa Laboratories Inc., focusing on the company's Q2 2023 results. The report analyzes key financial metrics such as earnings per share (EPS), revenue, net loss, inventories, and accounts receivable. Additionally, it provides a brief context by highlighting Mesa Laboratories Inc.'s recent stock performance. Financial Results Analysis: 1. EPS and Net Loss: In Q2 2023, Mesa Laboratories Inc. reported a loss of $0.10 per share, a significant improvement from the loss of $0.27 per share in the same period last year. Additionally, the current EPS represents a decline from the previous quarter's $0.11 per share. The company's net loss for the quarter was $-0.549 million, a positive shift from the $-1.438 million net loss reported in the corresponding period a year ago.
|
Mesa Laboratories Inc
Mesa Laboratories Inc, the Colorado-based electronic instruments and controls company, is showing signs of profitability according to their latest financial reports. The newest fiscal period saw a positive income of $0.11 per share - a significant improvement from $-0.33 a year before. Additionally, income grew by 37.02% from $0.08 per share in the previous reporting period. While revenue decreased by -5.584% to $55.59 million compared to the same reporting season the year before, sequentially revenue grew by 2.402% from $54.29 million. However, the company expressed satisfaction with their new bottom-line, achieving $0.611 million in the most recent fiscal period. This is a marked improvement from a net shortfall of $-1.784 million reported in the same period a year ago.
|
Per Share |
Current |
Earnings (TTM) |
0.17 $ |
Revenues (TTM) |
39.43 $
|
Cash Flow (TTM) |
0.39 $ |
Cash |
5.23 $
|
Book Value |
74.68 $
|
Dividend (TTM) |
0.8 $ |
|
Per Share |
|
Earnings (TTM) |
0.17 $
|
Revenues (TTM) |
39.43 $ |
Cash Flow (TTM) |
0.39 $ |
Cash |
5.23 $
|
Book Value |
74.68 $ |
Dividend (TTM) |
0.8 $ |
|
|
|
|